CIBC Private Wealth Group’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$818 Hold
302
﹤0.01% 2957
2025
Q3
$1.28K Buy
302
+40
+15% +$176 ﹤0.01% 2784
2025
Q2
$1.3K Sell
262
-124
-32% -$539 ﹤0.01% 2725
2025
Q1
$1.58K Sell
386
-336
-47% -$1.58K ﹤0.01% 2738
2024
Q4
$3.09K Sell
722
-181
-20% -$995 ﹤0.01% 2613
2024
Q3
$6.27K Sell
903
-382
-30% -$3K ﹤0.01% 2537
2024
Q2
$10.5K Buy
1,285
+300
+30% +$2.22K ﹤0.01% 2277
2024
Q1
$6.99K Buy
+985
New +$6.52K ﹤0.01% 2409
2022
Q3
Sell
-43
Closed 1012
2022
Q2
$0 Sell
43
-22,116
-100% -$246K ﹤0.01% 1235
2022
Q1
$429K Sell
22,159
-535,443
-96% -$12.3M ﹤0.01% 779
2021
Q4
$18.2M Buy
557,602
+211,090
+61% +$8.49M 0.04% 277
2021
Q3
$14.2M Sell
346,512
-2,484
-0.7% -$90.1K 0.03% 301
2021
Q2
$12.6M Buy
348,996
+134,924
+63% +$4.98M 0.03% 319
2021
Q1
$8.35M Sell
214,072
-1,241
-0.6% -$55.8K 0.02% 347
2020
Q4
$8.69M Buy
215,313
+176,581
+456% +$8.11M 0.02% 340
2020
Q3
$2.15M Buy
+38,732
New +$2.05M 0.01% 452

Other funds holding GDRX

CIBC Private Wealth Group's GDRX Position: Q4 2025 in Review

CIBC Private Wealth Group held its GoodRx Holdings (GDRX) position steady in Q4 2025 at 302 shares worth $818. The position accounts for ﹤0.01% of the portfolio, ranked #2957.

CIBC Private Wealth Group first reported a position in GDRX in Q3 2020 and has held it in 16 quarters since. The position peaked at $18.2M in Q4 2021. 183 funds tracked by Wall St. Rank hold GDRX as of Q4 2025.

  • CIBC Private Wealth Group held 302 shares of GoodRx Holdings worth $818 as of Q4 2025.
  • CIBC Private Wealth Group left its GoodRx Holdings share count unchanged in Q4 2025.
  • GoodRx Holdings made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2957 holding.
  • CIBC Private Wealth Group first reported a position in GoodRx Holdings in Q3 2020 and has held it in 16 quarters since.
  • CIBC Private Wealth Group's GoodRx Holdings position peaked at $18.2M in Q4 2021.
  • 183 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.